|
PALB2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.654800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.867000E-01 |
| Normal-vs-Stage2 |
7.730400E-01 |
| Normal-vs-Stage3 |
3.282400E-02 |
| Normal-vs-Stage4 |
3.042600E-01 |
| Stage1-vs-Stage2 |
2.669000E-01 |
| Stage1-vs-Stage3 |
2.950700E-04 |
| Stage1-vs-Stage4 |
3.696000E-02 |
| Stage2-vs-Stage3 |
1.363430E-01 |
| Stage2-vs-Stage4 |
5.662600E-01 |
| Stage3-vs-Stage4 |
3.201400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.714000E-01 |
| Normal-vs-AfricanAmerican |
4.282200E-01 |
| Normal-vs-Asian |
1.022400E-01 |
| Caucasian-vs-AfricanAmerican |
4.794800E-01 |
| Caucasian-vs-Asian |
1.454240E-01 |
| AfricanAmerican-vs-Asian |
1.091800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.876000E-01 |
| Normal-vs-Female |
7.760000E-01 |
| Male-vs-Female |
9.612000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.145600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.062200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.987400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.838000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.829200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.214600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.001600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.401190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.382000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.075180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.637800E-02 |
| Normal-vs-Grade 2 |
4.912000E-01 |
| Normal-vs-Grade 3 |
4.096600E-01 |
| Normal-vs-Grade 4 |
1.230410E-01 |
| Grade 1-vs-Grade 2 |
1.771000E-01 |
| Grade 1-vs-Grade 3 |
2.205500E-02 |
| Grade 1-vs-Grade 4 |
2.074100E-02 |
| Grade 2-vs-Grade 3 |
5.818100E-02 |
| Grade 2-vs-Grade 4 |
2.520200E-02 |
| Grade 3-vs-Grade 4 |
2.780400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.132210E-01 |
| Normal-vs-ccB subtype |
2.190000E-01 |
| ccA subtype-vs-ccB subtype |
7.351700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.864400E-01 |
| Normal-vs-N1 |
8.784000E-01 |
| N0-vs-N1 |
8.568200E-01 |
|
|
